AstraZeneca sues Mylan after securing fresh delivery patent on Symbicortnews2022-05-03T13:35:56+00:00May 3rd, 2022|Fierce Pharma|
Opiant beats path to FDA after nasal overdose drug matches Narcannews2022-05-03T13:27:38+00:00May 3rd, 2022|Fierce Pharma|
Bayer taps celebrity designers Nate Berkus and Jeremiah Brent for Claritin backyard makeover contestnews2022-05-03T13:21:26+00:00May 3rd, 2022|Fierce Pharma|
Novartis’ Netflix moment? Big Pharma launches new on-demand video hub to boost digital engagement with doctorsnews2022-05-03T13:20:54+00:00May 3rd, 2022|Fierce Pharma|
CordenPharma, part of Germany’s mRNA contingency plan, sold to private equity outfit Astorgnews2022-05-03T13:19:07+00:00May 3rd, 2022|Fierce Pharma|
FDA spurns Coherus and Junshi’s China-made PD-1 cancer drugnews2022-05-03T12:06:09+00:00May 3rd, 2022|Fierce Pharma|
Boehringer Ingelheim encourages women to ‘hear their heart’news2022-05-03T11:53:31+00:00May 3rd, 2022|Fierce Pharma|
GlaxoSmithKline trade secret theft case strikes down Swiss scientist, its 5th target, in convictionnews2022-05-03T11:10:38+00:00May 3rd, 2022|Fierce Pharma|
4% success? Pharma’s ‘conservative nature’ dooms digital product launches, report findsnews2022-05-03T09:48:06+00:00May 3rd, 2022|Fierce Pharma|
Teva settlement prevents Lupin from launching its Austedo generic until 2033news2022-05-02T19:04:51+00:00May 2nd, 2022|Fierce Pharma|
